Compare
Health Catalyst, Inc. vs System1, Inc. vs Cardlytics, Inc. vs Grindr Inc.
| Latest fiscal year | Health Catalyst, Inc. HCAT | System1, Inc. SST | Cardlytics, Inc. CDLX | Grindr Inc. GRND |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $311.14M | $266.13M | $233.27M | $439.90M |
| Revenue growth (YoY) | +1.5% | -22.6% | -16.2% | +27.6% |
| Gross margin | n/a | 37.7% (computed) | n/a | n/a |
| Operating margin | -51.7% | -23.3% | -43.6% | 28.7% |
| Net margin | -57.2% | -24.6% | -44.4% | 21.5% |
| Net income | -$177.97M | -$65.34M | -$103.49M | $94.75M |
| EPS (Diluted) | -$2.55 | -$8.32 | -$1.95 | $0.43 |
| Operating cash flow | $731.0K | -$4.15M | $9.29M | $141.52M |
| Free cash flow | -$237.0K | -$4.19M | $8.81M | $140.77M |
| Cash & equivalents | $50.81M | $86.89M | $48.72M | $87.05M |
| Total assets | $502.64M | $404.97M | $285.64M | $531.03M |
| Total liabilities | $256.86M | $387.55M | $292.15M | $484.02M |
| Shareholders' equity | $245.78M | $30.47M | -$6.51M | $47.01M |
| Return on year-end equity | -72.4% | -214.5% | n/a | 201.6% |
| Shares outstanding | 72.03M | n/a | 54.51M | 185.03M |
Revenue, most recent five fiscal years
| Fiscal year | Health Catalyst, Inc. | System1, Inc. | Cardlytics, Inc. | Grindr Inc. |
|---|---|---|---|---|
| Latest | $311.14M Ended 2025-12-31 | $266.13M Ended 2025-12-31 | $233.27M Ended 2025-12-31 | $439.90M Ended 2025-12-31 |
| 1 year earlier | $306.58M Ended 2024-12-31 | $343.93M Ended 2024-12-31 | $278.30M Ended 2024-12-31 | $344.64M Ended 2024-12-31 |
| 2 years earlier | $295.94M Ended 2023-12-31 | $401.97M Ended 2023-12-31 | $309.20M Ended 2023-12-31 | $259.69M Ended 2023-12-31 |
| 3 years earlier | $276.24M Ended 2022-12-31 | n/a | $298.54M Ended 2022-12-31 | $195.01M Ended 2022-12-31 |
| 4 years earlier | $241.93M Ended 2021-12-31 | $688.39M Ended 2021-12-31 | $267.12M Ended 2021-12-31 | $145.83M Ended 2021-12-31 |